Advancing women's health in the 21st century: Applying the tools of clinical pharmacology

Clinical Pharmacology and Therapeutics

Volumn 83, Issue 1, 2008, Pages 3-7

  Uhl, K ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CLINICAL PHARMACOLOGY; CONTRACEPTION; DRUG MARKETING; EDITORIAL; HEALTH; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE UTILIZATION; HUMAN; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICAL LITERATURE; MEDICAL PRACTICE; MEDICAL RESEARCH; MEDICARE; POLITICS; POSTMENOPAUSE; PRIORITY JOURNAL; PUBLIC FIGURE; PUBLIC HEALTH PROBLEM;

FEMALE; HISTORY, 21ST CENTURY; HUMANS; PHARMACOLOGY, CLINICAL; SEX FACTORS; TERMINOLOGY AS TOPIC; WOMEN'S HEALTH;

EID: 37549014538     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100463     Document Type: Editorial

References (16)

1. The North American Menopause Society. Menopause Practice: A Clinician's Guide 〈http://www.menopause.org/edumaterials/ cliniciansguide/cliniciansguide.htm〉 (2004).
2. Schwartz, J.B. The current state of knowledge on age, sex, and their interactions on clinical pharmacology. Clin. Pharmacol. Ther. 82, 87-96 (2007).
3. Wizemann, T.M. & Pardue, M.L., eds.; Institute of Medicine Committee on Understanding the Biology of Sex and Gender Differences. Exploring the Biological Contributions to Human Health: Does Sex Matter? 〈http://www.nap. edu/books/0309072816/html〉 (National Academies Press, Washington, DC, 2001).
4. Goetz, M.P., Kamal A. & Ames, M.M. Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response. Clin. Pharmacol. Ther. 83, 160-166 (2007).
5. Stoch, S.A. & Wagner, J.A. Cathepsin K inhibitors: a novel target for osteoporosis therapy. Clin. Pharmacol. Ther. 83, 172-176 (2008).
6. Moulder, S. & Hortobagyi, G.N. Advances in the treatment of breast cancer. Clin. Pharmacol. Ther. 83, 26-36 (2008).
7. National Center for Health Statistics. Health, United States, 2006, with chartbook on trends in the health of Americans (US Government Printing Office, Washington, DC, 2006).
8. Wenger, N.K., Shaw, L.J. & Vaccarino, V. Coronary heart disease in women: update 2008. Clin. Pharmacol. Ther. 83, 37-51 (2008).
9. Mount, G.R. & Gilliland, W.R. Emerging biological therapies in systemic lupus erythematosus. Clin. Pharmacol. Ther. 83, 167-171 (2008).
10. Gray, J.D. & Stewart, M.J. Looking at research through a different lens: the Canadian Institute of Gender and Health. Clin. Pharmacol. Ther. 83 188-191 (2008).
11. Oliva, A., Pinnow, E., Levin, R. & Uhl, K. Improving women's health through modernization of our bioinformatics infrastructure. Clin. Pharmacol. Ther. 83, 192-195 (2008).
12. Chambers, C.D., Polifka, J.E. & Friedman, J.M. Drug safety in pregnant women and their babies: ignorance is not bliss. Clin. Pharmacol. Ther. 83, 181-183 (2008).
13. Frederiksen, M.C. A needed information source. Clin. Pharmacol. Ther. 83, 22-23 (2008).
14. Greene, M.F. Emergency contraception: a reasonable personal choice or a destructive societal influence? Clin. Pharmacol. Ther. 83, 17-19 (2008).
15. Stanford, J.B. Emergency contraception: overestimated effectiveness and questionable expectations. Clin. Pharmacol. Ther. 83, 19-21 (2008).
16. Leung, V.W.Y., Soon, J.A., & Levine, M. Emergency contraception update: a Canadian perspective. Clin. Pharmacol. Ther. 83, 177-180 (2008).